Chronic Kidney Disease
Disparities identified in STGLT2 inhibitor use among Medicare-insured patients with CKD
Black and older patients with chronic kidney disease and insured by Medicare are less likely to start SGLT2 inhibitors or glucagon-like peptide 1 receptor agonists than second-generation sulfonylureas, according to data in Kidney Medicine.
VIDEO: Use comprehensive approach for treatment of diabetes in chronic kidney disease
Revised clinical practice guidelines on diabetes management in chronic kidney disease have been released by the nonprofit organization Kidney Disease: Improving Global Outcomes, or KDIGO.
Measuring eGFR with cystatin C can strongly impact CKD staging
Measuring cystatin C-based eGFR strongly correlates with creatinine eGFR, but it can also have a significant impact on the staging of chronic kidney disease, according to data published in Kidney Medicine.
Guidelines for treating patients with diabetes, CKD updated to improve care
The Kidney Disease Improving Global Outcomes updated the clinical practice guidelines for treating patients with diabetes and chronic kidney disease to recommend new practices, according to a press release.
Living in the Southeastern ‘stroke belt’ of the US can be a risk factor for CKD
Among other risk factors, researchers identified living in the Southeastern “stroke belt” of the U.S. as an independent risk factor for chronic kidney disease, according to data published in the American Journal of Kidney Diseases.
Lower sodium limits in prepackaged foods may reduce death, CVD risk
Data suggest reducing sodium limits on prepackaged foods to comply with new WHO benchmarks could prevent nearly 1,800 deaths and thousands of related diseases on a population level in Australia per year, researchers reported.
Serum phosphorus levels largely increased since 2013 in US compared with other countries
Compared with patients in European countries and Japan, patients using in-center hemodialysis in the United States showed a significant increase in serum phosphorous levels , according to data published in Kidney Medicine.
Top in 2022 policy, politics: Medicare’s aggressive approach to CKD attracts providers
Changes in Medicare’s approach to chronic kidney disease, including the Advancing American Kidney Health initiative and End-Stage Renal Disease Treatment Choice Model, attracted providers and value-based care groups.
Shrunken pore syndrome prognostic of contrast-induced kidney injury in PCI
The shrunken pore syndrome phenotype of renal dysfunction after PCI may be a stronger predictor of contrast-induced acute kidney injury compared with chronic kidney disease, researchers reported.
Soy protein in low protein diets increases cardioprotection in patients with CKD
Soy protein plus ketoanalogues of essential amino acids produced a larger effect on nephroprotection and cardioprotection in patients with stages 3b to 4 chronic kidney disease than a conventional low protein diet, researchers reported.